April 23, 2024

International Coalition for Drug Awareness

A Group of physicians, researchers, Journalists and concerned citizens dedicated to educating about the dangers posed by many Rx medicines.

Random News
ICFDA Warning

venlafaxine

SSRIs: Sharp Drop in Brain Activity + Worsening Depression & Suicidality

Ann Blake-Tracy09 mins

hile antidepressant medications have proven to be beneficial in helping people overcome majordepression, it has long been known that a small subset of individuals taking these drugs can actually experience a worsening of mood, and even thoughts of suicide. No clinical test currently exists to make this determination, and only time usually weeks can tell before a psychiatrist knows whether a patient is getting better or worse.

Now, UCLA researchers have developed a non-invasive biomarker, or indicator, that may serve as a type of early warning system.

Reporting in the April edition of the peer-reviewed journal Acta Psychiatrica Scandinavica, Aimee Hunter, an assistant research psychologist in the UCLA Department of Psychiatry, and colleagues report that by using quantitative electroencephalographic (QEEG), a non-invasive measurement of electrical activity in the brain, they were able to observe a sharp reduction of activity in a specific brainregion in individuals who proved susceptible to thoughts of suicide within 48 hours of the start of treatment.

Read More

EFFEXOR: Death/Possible Suicide: England

Ann Blake-Tracy07 mins

Paragraph four reads:  “Post-mortem tests showed the 44-year-old had three times the fatal dose of the anti-depressant venlafaxine [Effexor] in her body.” Fourth paragraph from the end reads:  “Mr Williams recorded an open verdict.” Mr Bray said before her death she seemed “happy as a lord”, even though she had been threatened with eviction from…

Read More

Kauffman Study – (SSRI) Drugs: More Risks Than Benefits?

Ann Blake-Tracy255 mins

As the number of “anecdotes” exceeds 1,600—hardly a small number—the association of SSRIs with murder/suicide, often combined, must be taken seriously. The SSRI website was searched to find combined murder/suicide incidents attributed to a specific SSRI. There were three for fluvoxamine, four for citalopram, 10 each for paroxetine and sertraline, and 31 for fluoxetine. Where the studies above substantiated suicide from SSRI use, the total on the SSRI website of 48 simultaneous murder/suicide incidents associated with SSRI use ties together SSRIs and murder. Since there were about two murders per suicide, we may infer that the murder rate on SSRIs could be about 250/100,000. Since no clinical trial involving multiple homicides is ever likely to be run, no firmer evidence is likely to be found. Healy noted that much of the evidence for suicide and murder came from the efforts of journalists and lawyers.

Read More